Wall Street Experts
ver. ZuMIgo(08/25)
Intellia Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 46
EBIT TTM (mln): -524
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| Rok finansowy |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
0 |
6 |
16 |
26 |
30 |
43 |
58 |
33 |
52 |
36 |
58 |
| Przychód Δ r/r |
0.0% |
inf% |
172.7% |
58.5% |
16.5% |
41.6% |
34.5% |
-43.0% |
57.7% |
-30.4% |
59.6% |
| Marża brutto |
-inf% |
-84.8% |
-93.2% |
-159.0% |
-192.8% |
-151.5% |
-159.4% |
79.2% |
85.5% |
75.3% |
100.0% |
| EBIT (mln) |
-5 |
-13 |
-32 |
-70 |
-91 |
-106 |
-137 |
-268 |
-458 |
-515 |
-534 |
| EBIT Δ r/r |
0.0% |
156.6% |
139.8% |
116.3% |
30.6% |
17.1% |
28.4% |
96.1% |
71.1% |
12.5% |
3.7% |
| EBIT (%) |
0.0% |
-221.9% |
-195.2% |
-266.3% |
-298.6% |
-246.8% |
-235.5% |
-810.4% |
-879.0% |
-1420.5% |
-923.1% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EBITDA (mln) |
-5 |
-13 |
-31 |
-67 |
-86 |
-101 |
-130 |
-261 |
-451 |
-506 |
-524 |
| EBITDA(%) |
0.0% |
-216.4% |
-188.5% |
-254.9% |
-283.9% |
-233.8% |
-224.6% |
-789.5% |
-864.5% |
-1395.8% |
-905.3% |
| Podatek (mln) |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-14 |
-12 |
-32 |
-68 |
-85 |
-100 |
-134 |
-268 |
-474 |
-481 |
-519 |
| Zysk netto Δ r/r |
0.0% |
-13.4% |
155.2% |
113.5% |
26.4% |
16.6% |
34.9% |
99.6% |
77.0% |
1.5% |
7.9% |
| Zysk netto (%) |
0.0% |
-205.1% |
-192.0% |
-258.6% |
-280.4% |
-230.9% |
-231.5% |
-810.5% |
-909.8% |
-1326.5% |
-896.8% |
| EPS |
-29.45 |
-51.02 |
-1.42 |
-1.88 |
-1.98 |
-2.11 |
-2.4 |
-3.78 |
-6.16 |
-5.42 |
-5.25 |
| EPS (rozwodnione) |
-29.45 |
-51.02 |
-1.42 |
-1.88 |
-1.98 |
-2.11 |
-2.4 |
-3.78 |
-6.16 |
-5.42 |
-5.25 |
| Ilośc akcji (mln) |
0 |
0 |
22 |
36 |
43 |
47 |
56 |
71 |
77 |
89 |
99 |
| Ważona ilośc akcji (mln) |
0 |
0 |
22 |
36 |
43 |
47 |
56 |
71 |
77 |
89 |
99 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |